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Summary
What is already known on this topic?
Analyses of health systems interventions on chronic disease management
and the variation of clinical quality improvement percent scores is limited.
What is added by this report?
This study underscores the variability that can occur within and across fed-
erally qualified health centers in Illinois around the number and type of
policies, systems, and processes implemented.
What are the implications for public health practice?
When considering the tactics of implementing evidence-based chronic dis-
ease management, health systems should consider the difference
between the number and types of policies, systems, and processes that
address hypertension and diabetes control.
Abstract
Introduction
Evidence-based interventions (referral, team-based care, self-man-
agement, and self-monitoring) for chronic disease management are
well documented and widely used by Federally Qualified Health
Centers (FQHCs). However, how these interventions are imple-
mented varies substantially.
Methods
The Illinois Health Information Systems Survey was deployed to
49 FQHCs. Responses were grouped into 4 distinct policies, sys-
tems, and processes (P/S/P) categories: internal policies/work-
flows, huddles (brief meetings), electronic health record alerts/
tracking  tools,  and  case  manager/coordinator  interaction.  Re-
sponses were then direct-matched to the 2016 Health Resources
and Services and Administration Uniform Data System clinical
quality indicator (QI) percent scores. Descriptive statistics were
generated and level of significance (P < .05) was tested for hyper-
tension and type 2 diabetes mellitus.
Results
The total number of P/S/Ps in place for hypertension ranged from
0 to 13 (mean, 6.9) and 0 to 8 for diabetes (mean, 5.1). Meeting or
exceeding the national mean QI percent score for controlled blood
pressure (62.4%) was significant among FQHCs with 9 or more P/
S/Ps compared with those with 8 or fewer P/S/Ps. A positive asso-
ciation in clinical QI percent score was found among organiza-
tions that had 3 or more P/S/Ps (for all 4 intervention areas), al-
though none were significant.
Conclusion
An assessment of the types of P/S/Ps used to implement evidence-
based interventions for hypertension and diabetes management is a
first in Illinois. Initial results support some relationship between
the number of P/S/Ps implemented and clinical QI percent score
for both hypertension and diabetes.
Introduction
Hypertension and diabetes are risk factors for cardiovascular dis-
ease (CVD) and related conditions and can lead to premature death
(1). Approximately 1 in 7 health care dollars is spent on CVD (2).
In the United States, hypertension affects nearly 78 million adults
aged 18 years or older and is a major modifiable risk factor for
other CVDs and stroke. Additionally, it is estimated that 1 in 9
adults in the United States have diabetes (1). Diabetes (blood gluc-
ose) management plays a critical role in prevention of CVD (3).
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Long-term complications of high glucose levels and type 2 dia-
betes mellitus include CVD, renal failure, nerve damage, and ret-
inal damage (4).
A comprehensive approach that incorporates evidence-based inter-
ventions is critical to address the multiple comorbidities and risk
factors of CVD. Interventions adopted by health systems to ad-
dress hypertension, diabetes, and other chronic diseases have shif-
ted toward using a population health management approach (an in-
terdisciplinary, customizable approach that allows health depart-
ments to connect practice to policy for change to happen locally
[5]) for improved disease management and coordination of care.
This is even more important in underserved communities, specific-
ally among Federally Qualified Health Centers (FQHCs), given
their resource-constrained environment (6) and the high-risk popu-
lations they serve.
Studies show a higher prevalence of hypertension and diabetes
among populations served by FQHCs, such as minority and low-
income groups (7–9). Nationally, FQHCs provide health care ser-
vices to people who are geographically isolated or economically or
medically vulnerable. Investments in FQHCs reduce costs for loc-
al  health care systems and provide economic benefits  for  sur-
rounding communities (10). FQHCs track demographic, clinical
quality, and cost of care data and provide annual reports via the
Uniform Data System (UDS) to the Health Resources and Ser-
vices Administration (HRSA). Clinical quality improvement (QI)
percent scores are national measures monitored by HRSA among
FQHCs that receive federal funding and are used to monitor and
improve the quality of perinatal, chronic disease, and preventive
care services. These measures typically align with health care and
public health measures such as Healthy People 2020. For con-
trolled blood pressure, a higher clinical QI percent score is better
(ie, more patients with controlled blood pressure) whereas for poor
glycemic control a lower clinical QI percent score is better (ie,
fewer patients with poor glycemic control). Given the variability
of resources, organizational supports, community linkages, and in-
formation technology infrastructure, the ability of FQHCs to im-
plement evidence-based interventions and improve QI percent
scores can vary widely. The aim of this study was to understand
variations in clinical QI percent scores by the types of evidence-
based interventions implemented in support of hypertension and
diabetes management within FQHCs in Illinois in 2016.
Methods
Database and survey instrument
This is a cross-sectional study using data from the 2017 Illinois
Health Information Systems Survey (IL-HISS). The IL-HISS was
developed as an original survey to support performance monitor-
ing for a subset of chronic disease programs in the Illinois Depart-
ment of Public Health (IDPH). In the survey, 21 questions were
related to quality improvement policies, systems, and processes
(P/S/Ps) that health systems have implemented in support of evid-
ence-based interventions to manage patients with hypertension and
diabetes (Appendix). The questions addressed evidence-based in-
terventions such as electronic health record (EHR) capabilities,
meaningful use, quality reporting, team-based care, referrals, self-
monitoring, and self-management plans. Within each intervention,
respondents were able to select 1 or more P/S/P types that have
been implemented for the respective intervention. Responses were
analyzed for common themes and grouped accordingly as either
internal policies/workflows, huddles (10-minute or less stand-up
meetings used to foster communication in a clinical setting [11]),
EHR alerts/tracking tools, and case manager/coordinator interac-
tion. Responses were then dichotomized as yes or no for each P/S/
P category. P/S/P scores were then generated based on the num-
ber of P/S/Ps the organization had in place for each intervention.
IL-HISS responses were direct-matched with the 2016 UDS file
for Illinois to include demographic characteristics and clinical QI
percent scores for controlled high blood pressure (<140/90 mm
Hg) and poor glycemic control (hemoglobin A1c >9%) (12).
Study population
The IL-HISS was deployed to 49 Illinois Primary Health Care As-
sociation (IPHCA)-member FQHCs, with a 63.3% response rate
(n = 32). Non-IPHCA member FQHCs were not excluded from
participating in the survey. However, the survey was not directly
promoted to  those  organizations  (n  < 10).  To increase  survey
awareness and participation, a strategic survey dissemination pro-
cess was created and carried out as follows: the survey was 1) co-
developed and co-endorsed by IDPH and the IPHCA; 2) intro-
duced and vetted through IPHCA’s Clinical Leadership commit-
tee; 3) pilot tested with clinical and QI managers from 3 FQHCs;
and 4) deployed electronically through the organizations’ execut-
ive leadership and quality managers. All 3 pilot sites participated
in the live survey following the testing process. All invited parti-
cipants were given 3 weeks to respond to the survey with a single
1-week extension. Clinical directors or quality management teams
were asked to report on activities occurring between January 1 and
December 31, 2016. Descriptive statistics were generated as well
as cumulative and within-category P/S/P scores for hypertension
and diabetes.
Statistical analysis
Patient demographic and clinical quality characteristics (perinatal
health, preventive health screenings and services, and chronic dis-
ease management) among centers that responded to the IL-HISS
survey (respondents) and centers that did not respond to the sur-
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vey (nonrespondents) were compared using a 2-sample t test as-
suming equal variances, based on the Behrens-Fisher test, to de-
termine if there were significant differences. Descriptive and stat-
istical  tests were conducted for IL-HISS respondents by using
SAS version 9.4 (SAS Institute, Inc).
Chi-squared and Fisher exact test (for cells less than 5) were used
to test significant differences in clinical QI mean scores (hyperten-
sion and diabetes) for systems with less than 3 versus 3 or more P/
S/Ps cumulatively (across all intervention types) as well as within
each intervention. Further analysis was conducted to understand
the variation of the number of P/S/Ps overall and within a specific
evidence-based intervention, looking specifically at meeting or ex-
ceeding Healthy People 2020 goals (13) and the 2016 national
UDS mean clinical  QI percent  score (14) for  controlled blood
pressure (61.5% and 62.4%, respectively) and poor glycemic con-
trol (16.2% and 32.1%, respectively). Respondents were dicho-
tomized on the basis of the total number of P/S/Ps selected overall
and within intervention. Overall P/S/Ps were grouped based on be-
ing above or below the midpoint of the maximum number of pos-
sible P/S/Ps; 0 to 8 versus 9 to 16 for controlled blood pressure
overall, 0 to 4 versus 5 to 8 for poor glycemic control overall, and
3 or more P/S/Ps for within-intervention analysis. For all analyses,
P < .05 was considered significant.
Results
Demographic and clinical characteristics for hypertension and dia-
betes varied slightly but were not significantly different between
patients of survey respondents and nonrespondents. A higher mean
difference between respondents and nonrespondents was noted for
all racial/ethnic groups as well as for uninsured patients, but was
not significant. In addition, the mean for the number of patients
with hypertension and diabetes varied by less than 0.5%, and the
centers’ clinical QI percent scores for the number of patients with
controlled blood pressure and poor glycemic control varied by less
than 2.5% between respondents and nonrespondents; both find-
ings were not significant.
Survey respondents had a mean patient population of 23,784 (min-
imum, 2,658; maximum, 102,739). All respondents indicated hav-
ing an EHR, 84.3% achieved Patient Centered Medical Home ac-
creditation, 78% reported national quality measures for both hy-
pertension and diabetes, and 53.1% used supplemental EHR soft-
ware packages for QI interventions in 2016. Out of a maximum al-
lowable P/S/P score of 16 for hypertension (4 P/S/P categories
across 4 interventions), the mean number of P/S/Ps related to con-
trolled blood pressure interventions was 6.9 (95% confidence in-
terval [CI], 5.5–8.3) (Table 1). Out of a maximum allowable P/S/P
score of 8 for diabetes (4 P/S/P categories across 2 interventions),
the mean number of P/S/Ps related to poor glycemic control inter-
ventions was 5.1 (95% CI, 4.3–5.9). The mean UDS clinical QI
percent score for controlled blood pressure was 64.9% and poor
glycemic control was 33.1%, compared with the UDS mean of
62.4% and 32.1%, respectively (14). FQHCs that met or exceeded
the Healthy People 2020 target of 61.5% for controlled blood pres-
sure had an average of 7.7 P/S/Ps versus 6.1 P/S/Ps among those
that  did  not  meet  the  target.  FQHCs that  met  or  exceeded the
Healthy People 2020 target of 16.2% for poor glycemic control
had 5.0 P/S/Ps versus 4.7 among those that did not meet the target
(Table 1).
The most frequent P/S/P categories across hypertension and dia-
betes  combined  were  internal  programs/workflows  (78.1%),
huddles (65.6%),  EHR alerts/tracking tools  (53.1%),  and case
manager/coordinator interaction (40.6%) (Figure). These frequen-
cies were consistent when looking at hypertension and diabetes
alone.
Figure. Percentage of Federally Qualified Health Centers that implemented
policies,  systems,  and processes (P/S/Ps)  for  hypertension management
interventions, type 2 diabetes mellitus management interventions, and both
interventions combined, by P/S/P type, Illinois, 2016. Huddles are defined as
10-minute  or  less  stand-up meetings  used to  foster  communication in  a
clinical setting (11).
The highest percentage of P/S/Ps was the use of internal programs/
workflows for the following interventions: referral to self-manage-
ment programs for hypertension (81.2%; 95% CI, 66.9–95.5), re-
ferral to self-management programs for diabetes (80.6%; 95% CI,
65.9–95.4),  and team-based care for diabetes (75.0%; 95% CI,
59.1–90.7) (Table 2). Huddles and EHR alerts/tracking tools were
implemented more frequently for team-based care interventions
for  hypertension (62.5% and 56.3%) and diabetes (68.8% and
62.5%) than for other types of interventions. The use of a case
manager/coordinator interaction was implemented more often for
team-based care for diabetes (40.6%), referral to self-management
PREVENTING CHRONIC DISEASE VOLUME 17, E08
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY     JANUARY 2020
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
www.cdc.gov/pcd/issues/2020/19_0058.htm • Centers for Disease Control and Prevention       3
programs for diabetes (37.5%), and self-management plan for hy-
pertension (37.5%) than for other types of interventions (Table 2).
For controlled blood pressure, there was a significant difference (P
< .05) in meeting or exceeding the national mean clinical QI per-
cent  score among FQHCs that  implemented 9 or  more P/S/Ps.
Within each intervention category, there was a positive associ-
ation between the percentage of FQHCs that had 3 or more P/S/Ps
in place and met or exceeded the national mean clinical QI per-
cent  score  for  all  hypertension  and  diabetes  interventions.
However, none were significant (Table 3).
Discussion
FQHCs achieve higher clinical QI percent scores for their patients
with diabetes and hypertension compared with the national aver-
age (17). However, variation exists around what types and how
many P/S/Ps are used to implement those evidence-based inter-
ventions among Illinois FQHCs. The FQHCs that responded to the
IL-HISS indicated a high level of commitment to quality based on
positive responses around Patient Centered Medical Home accred-
itation, meaningful use, use of supplemental QI software, and oth-
er attributes. In addition, our study showed that there was a posit-
ive association in the number of interventions implemented and
mean clinical QI percent score for controlled hypertension (linear
relationship) and poor glycemic control (inverse relationship).
National policy changes, such as Medicaid expansion, could have
had an impact on the UDS clinical QI percent scores for FQHCs in
Illinois (10). One study found that at federally funded community
health centers, Medicaid expansion was associated with improved
clinical quality for 4 of the 8 measures examined: asthma treat-
ment, Papanicolaou testing, body mass index assessment, and con-
trolled blood pressure (18). Additionally, our study did not ac-
count  for  patient-specific  demographics  and other  factors  like
medication adherence, encounter frequency, and health literacy
that affect chronic disease management (19–21). IL-HISS data are
based on self-reported data. The study was cross-sectional and
cannot conclude that the improved scores were due to the number
or types of P/S/Ps implemented, only the association with them.
Lastly, there is a possibility of nonresponse bias as a result of the
methods used to collect these data.
There is growing evidence that use of P/S/Ps across health sys-
tems to improve the quality of chronic care is effective and vital to
improving health outcomes (22). Our study focused on a subset of
elements that address systematic supports around the implementa-
tion of evidence-based interventions that affect clinical QI percent
scores. It may be useful to the public health community to study
these elements in more detail. These could include availability of
community resources, the level of leadership and decision support,
and systems of care design to further assess interactions between
health systems, care teams, and patients (23). The information
gathered for our study will be used to improve training and tech-
nical assistance for FQHCs; specifically, in areas where gaps were
identified (eg, increase the use of evidence-based interventions for
blood pressure self-monitoring and self-management plans). Al-
though the results of our study are not generalizable across states,
they might be valuable for other states, territories, and local health
jurisdictions to replicate this type of analysis to inform effective
mechanisms (ie, types of P/S/Ps) that can be used to implement
and sustain evidence-based interventions for hypertension and dia-
betes.
Initial results support some relationship between the number of P/
S/Ps implemented and clinical QI percent score for both hyperten-
sion and diabetes. Given constraints in resources, staff time, and
organizational infrastructure to support new or enhanced QI ef-
forts, health systems would benefit from knowing what P/S/Ps
work best for their organization. As the narrative around health
care management and quality evolves, so too should the under-
standing around what composites of P/S/Ps have the greatest im-
pact on health care outcomes for hypertension and diabetes.
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Tables
Table 1. Policies, Systems, and Processes (P/S/Ps); Clinical Quality Improvement (QI) Percent Scores; and Healthy People 2020 Targets for Controlled Blood Pres-
sure and Hemoglobin A1c >9%, Illinois, 2016
Category
No. of P/S/Ps Clinical QI Percent Scorea Mean No. of P/S/Psb
Mean (95% CI) Minimum Maximum Mean SD Below 2020 Target Above 2020 Target
Controlled blood pressurec 6.9 (5.5–8.3) 49.3% 85.4% 64.9% 8.9 6.1 7.7
Hemoglobin A1c >9%
d 5.1 (4.3–5.9) 13.9% 62.0% 33.1% 11.6 5.0 4.7
a Clinical QI percent score data collected from the Health Resources and Services Administration Uniform Data System, 2016 Illinois Report (14).
b Mean number of P/S/Ps calculated and grouped as being above or below the Healthy People 2020 target for controlled high blood pressure (61.5%) (15) and for
poor glycemic control (16.2%) (16).
c Controlled blood pressure = percentage of patients aged 18–85 years who had a diagnosis of hypertension and whose blood pressure was adequately controlled
(<140/90 mm Hg) during the measurement period. Higher percentage score indicates positive clinical outcome.
d Hemoglobin A1c >9% = percentage of patients aged 18–75 years with diabetes who had hemoglobin A1c >9.0% during the measurement period. A lower percent-
age score indicates positive clinical outcome.
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Table 2. Percentages of FQHCs Indicating Use of P/S/Ps, by Evidence-based Intervention and P/S/P Category, Illinois, 2016
Evidence-based
Intervention
P/S/P Category
Internal Programs/Workflows,
% (95% CI)
Huddlesa,
% (95% CI)
EHRa Alerts/Tracking Tools,
% (95% CI)
Case Manager/Coordinator,
% (95% CI)
Referral to self-management programs
Hypertension 81.2 (66.9–95.5) 43.8 (25.6–61.9) 34.4 (17.0–51.8) 21.9 (6.7–37.0)
Diabetes 80.6 (65.9–95.4) 59.4 (41.4–77.4) 34.4 (17.0–51.8) 37.5 (19.8–55.2)
Team-based care
Hypertension 59.4 (41.4–77.4) 62.5 (44.8–80.2) 56.3 (38.1–74.4) 28.1 (11.7–44.6)
Diabetes 75.0 (59.1–90.7) 68.8 (51.8–85.7) 62.5 (44.8–80.2) 40.6 (22.6–58.6)
Blood pressure self-monitoring
Hypertension 34.4 (17.0–51.8) 40.6 (22.6–58.6) 40.6 (22.6–58.6) 6.3 (0–15.1)
Self-management plan
Hypertension 43.7 (25.6–61.9) 21.9 (6.7–37.0) 50.0 (31.7–68.3) 37.5 (19.8–55.2)
Abbreviations: CI, confidence interval; EHR, electronic health record; FQHC, Federally Qualified Health Center; P/S/Ps, policies, systems, and processes.
a Defined as 10-minute or less stand-up meetings used to foster communication in a clinical setting (11).
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Table 3. Overall and Within Interventions at or Below the Mean National Uniform Data System Clinical Quality Improvement Percent Score for Controlled High Blood
Pressure and Poor Glycemic Control, Illinois, 2016
All P/S/P Categoriesa (Combined) % Did Not Meet % Met or Exceeded P Valueb
No. with controlled blood pressurec,d
0–8 71.4 36.8
.049
9–16 28.6 63.2
No. with poor glycemic control (hemoglobin A1c >9%)d,e
0–4 68.8 64.7
.81
5–8 31.2 35.3
Interventions (3 or more P/S/Ps)f
Referral (blood pressure) 28.6 42.1 .49
Team-based care (blood pressure) 35.7 63.2 .12
Self-monitoring (blood pressure) 7.1 21.1 .37
Self-management plan (blood pressure) 7.1 36.8 .10
Referral (diabetes) 37.5 41.2 .83
Team-based care (diabetes) 37.5 64.7 .12
Abbreviation: P/S/P, policies, systems, and processes.
a P/S/P categories were internal policies/workflows, huddles (10-minute or less stand-up meetings used to foster communication in a clinical setting [11]), elec-
tronic health record alerts/tracking tools, and case manager/coordinator interaction.
b P < .05 was considered significant.
c National mean Health Resources and Services Administration Uniform Data System score (2016) for controlled blood pressure, was 62.4% (14).
d χ2 test.
e National mean Health Resources and Services Administration Uniform Data System score (2016) for hemoglobin A1c >9% was 32.1% (14).f Fisher exact test was used to test level of significance when sample size was <5.
PREVENTING CHRONIC DISEASE VOLUME 17, E08
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY     JANUARY 2020
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
8       Centers for Disease Control and Prevention  •  www.cdc.gov/pcd/issues/2020/19_0058.htm
Appendix. 2017 Illinois Health Information Systems Survey
Organizational Information:
Organization Name and Number of Sites1.
Current EHR system used within your organization and certification status2.
Does your organization use supplemental EHR software to support quality improvement and reporting efforts (eg, i2i, Azara, Mediquire, etc)?3.
What is the current status of Medical Home recognition within your organization?4.
Quality Reporting and Meaningful Use:
Has your organization reported on the National Quality Forum (NQF) Measure 0018 / Physician Quality Reporting System (PQRS) 236 in the past 12 months?1.
Has your organization reported on the NQF Measure 0059 in the past 12 months?2.
Does your organization use an EHR appropriate for treating patients (adults ≥18 years old) with high BP and/or diabetes?3.
Indicate the current stage (1, 2, or 3) of meaningful use and existing barriers to achieving meaningful use.4.
Electronic Health Record (EHR) Capabilities:
Does your EHR have the capability to generate a list of:1.
Adult patients (≥18 years old) with high BP and their BP reading for the past 12 months?a.
Adult patients (≥18 years old) that have high BP AND documentation of a self-management plan?b.
Adult patients (≥18 years old) diagnosed with diabetes?c.
Adult patients (≥18 years old) with an elevated blood glucose reading that are either undiagnosed as diabetic or that need follow-up?d.
Adult patients (≥18 years old) diagnosed with diabetes with a HbA1c reading >9%?e.
Policies, Systems, and Processes:
What current policies or systems are used to refer adult patients (≥ 18 years old) with high BP to self-management resources? Are referrals to self-manage-
ment resources being tracked?
1.
What current policies or systems are used to encourage a team-based care approach to high BP control?2.
What policies or systems are in place to encourage BP self-monitoring?3.
What are the policies or systems in place to encourage healthcare providers to prescribe a self-management plan to adult patients (≥18 years old) with high BP
and record the plan in the EHR?
4.
Describe the system and/or process to tracking referral of patients with diabetes to self-management programs in the community.5.
What existing policies or systems are in place to encourage a team-based care approach to HbA1c control?6.
What existing policies or systems are in place to encourage referral of persons with prediabetes or at high risk for type 2 diabetes to a CDC-recognized lifestyle
change program?
7.
Describe the system and/or process to tracking referral of persons with prediabetes or at high risk for type 2 diabetes to a CDC-recognized lifestyle change pro-
gram.
8.
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